We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTAP icon
276
NetApp
NTAP
$31.6B
$136K 0.01%
2,089
+958
+85% +$68.9K
ASND icon
277
Ascendis Pharma A/S
ASND
$17.3B
$134K 0.01%
1,438
+1,217
+551% +$115K
EMR icon
278
Emerson Electric
EMR
$79.5B
$134K 0.01%
1,684
– –
PPG icon
279
PPG Industries
PPG
$26.6B
$131K 0.01%
1,144
– –
VRSK icon
280
Verisk Analytics
VRSK
$26.4B
$131K 0.01%
759
+329
+77% +$61.4K
ADBE icon
281
Adobe
ADBE
$92.8B
$130K 0.01%
+354
New +$144K
AVB icon
282
AvalonBay Communities
AVB
$27.8B
$128K 0.01%
660
– –
BF.B icon
283
Brown-Forman Class B
BF.B
$12B
$127K 0.01%
1,808
+527
+41% +$35.3K
CABO icon
284
Cable One
CABO
$242M
$125K 0.01%
97
+58
+149% +$73.8K
STZ icon
285
Constellation Brands
STZ
$23.3B
$125K 0.01%
535
– –
SEE
286
DELISTED
Sealed Air
SEE
$123K 0.01%
2,134
-360,989
-99% -$22.8M
BR icon
287
Broadridge
BR
$17.5B
$122K 0.01%
858
+7
+0.8% +$1.02K
HAL icon
288
Halliburton
HAL
$29.5B
$120K 0.01%
3,826
– –
SIVB
289
DELISTED
SVB Financial Group
SIVB
$120K 0.01%
+303
New +$143K
EFX icon
290
Equifax
EFX
$21.2B
$119K 0.01%
651
– –
FITB
291
Fifth Third Bancorp
FITB
$52.2B
$119K 0.01%
+3,547
New +$133K
WST icon
292
West Pharmaceutical
WST
$25.7B
$119K 0.01%
394
-87
-18% -$28.3K
APH icon
293
Amphenol
APH
$186B
$118K 0.01%
+3,680
New +$128K
VTR icon
294
Ventas
VTR
$47.2B
$116K 0.01%
2,260
– –
PWR icon
295
Quanta Services
PWR
$94.3B
$115K 0.01%
920
+270
+42% +$33.1K
NTRS icon
296
Northern Trust
NTRS
$34.7B
$114K 0.01%
1,185
+425
+56% +$44.9K
GLW icon
297
Corning
GLW
$133B
$113K 0.01%
3,601
– –
SYY icon
298
Sysco
SYY
$39.8B
$112K 0.01%
1,326
-391
-23% -$32.8K
ARE icon
299
Alexandria Real Estate Equities
ARE
$8.75B
$111K 0.01%
766
+341
+80% +$57.9K
MAA icon
300
Mid-America Apartment Communities
MAA
$15.6B
$111K 0.01%
638
– –
10 11
12
13 14

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.